Endovascular treatment of pulmonary and cerebral arteriovenous malformations in patients affected by Hereditary Haemorrhagic Teleangiectasia

Current Pharmaceutical Design

Volumn 12, Issue 10, 2006, Pages 1243-1248

  De Cillis, E ^a   Burdi, N ^b   Bortone, A S ^a   D'Agostino, D ^a   Fiore, T ^a   Ettorre, G C ^c   Resta, M ^b  

^a UNIVERSITY OF BARI   (Italy)

^b SS Annunziata Hospital   (Italy)

^c UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Cerebral arteriovenous malformations (CAVM); Hereditary Haemorrhagic Teleangiectasia (HHT); Percutaneous transcatheter embolotherapy; Pulmonary arteriovenous malformations (PAVM)

Indexed keywords

AIR EMBOLISM; ARTERIOVENOUS FISTULA; ARTIFICIAL EMBOLISM; AUTOSOMAL DOMINANT DISORDER; BALLOON EMBOLIZATION; BLEEDING; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN ISCHEMIA; CATHETERIZATION; CLINICAL FEATURE; CLINICAL PROTOCOL; DIAGNOSTIC PROCEDURE; DISEASE MARKER; FOLLOW UP; GUIDE WIRE; HUMAN; INCIDENCE; LUNG ANGIOGRAPHY; LUNG DISEASE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PLEURISY; PRIORITY JOURNAL; RADIOSURGERY; RENDU OSLER WEBER DISEASE; REVIEW; RISK REDUCTION; STEREOTAXIC SURGERY; ANGIOGRAPHY; ARTERIOVENOUS MALFORMATION; LUNG CIRCULATION; PHYSIOLOGY;

ANGIOGRAPHY; ARTERIOVENOUS MALFORMATIONS; HUMANS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; PULMONARY CIRCULATION; TELANGIECTASIA, HEREDITARY HEMORRHAGIC;

EID: 33744975527     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161206776361237     Document Type: Review

References (22)

1. Berg JNE, Guttmacher D, Marchuk A, Porteus MEM. Clinical heterogeneity in hereditary haemorrhagic teleangiectasia: are pulmonary arteriovenous malformations more common in families linked to endoglin? J Med Genet 1996; 33: 256-257.
2. White RIJ, Mitchell SE, Barth KH, Kaufman S, Kadir S, Chang R, et al. Angioarchitecture of pulmonary arteriovenous malformations: an important consideration before embolotherapy. AJR 1983; 140: 681-686.
3. White RIJ, Lunch-Nyhan A, Terry P, Buescher C, Farmlett EJ, Charnas L, et al. Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy, Radiology 1988; 168: 663-669.
4. White RIJ, Pollak JS, Wirth A. Pulmonary arteriovenous malformations: diagnosis and transcatheter embolotherapy. J Vasc Int Radiol 1996; 7: 787-804
5. Faughnan ME, Lui YW, Wirth JA, Pugash RA, Redelmeier DA, Hyland RH, et al. Diffuse pulmonary arteriovenous malformations. Chest 2000; 117: 31-38.
6. Watanabe N, Munakata Y, Ogiwara M, Myatake M, Nakagawa F, Hirayama J. A case of pulmonary arteriovenous malformation in a patient with brain abscess successfully treated with video-assisted thoracoscopic resection. Chest 1995; 108: 1724-7.
7. Hewes RC, Auster M, White RIJ. Cerebral embolism: first manifestation of pulmonary arteriovenous malformation in patients with hereditary Haemorrhagic teleangiectasia. Cardiovasc Intervent Radiol 1985; 8: 151-155.
8. Remy-Jardin M, Wattinne L, Remy J. Transcatheter occlusion of pulmonary arterial circulation and collateral supply: failures, incidents and complications. Radiology 1991; 180: 699-705.
9. Bosher LH, Blake DA, Byrd BR. An analysis of the pathologic anatomy of pulmonary arteriovenous aneurysm with particular reference to the applicability of local excision. Surgery 1959; 45: 91-104.
10. Willinsky RA, Lasjaunias P, Ter Brugge K, Burrows P. Multiple cerebral arteriovenous malformations (AVMs): review of our experience from 203 patients with cerebral vascular lesions. Neuroradiology 1990; 32: 207-210.
11. Matsubara S, Manzia JL, Ter Brugge K, Willinsky RA, Montanera W, Faughnan ME. Angiographic and clinical characteristics of patients with cerebral arteriovenous malformations associated with hereditary Haemorrhagic telangiectasia. Am J Neuroradiol 2000; 21: 1016-1020.
12. Fulbright RK, Chaloupka JC, Putman CM, Sze GK, Merriam MM, Lee GK, et al. MR of hereditary Haemorrhagic telangiectasia: prevalence and spectrum of cerebrovascular malformations. Am J Neuroradiol 1998; 19: 477-484.
13. Kiluchi K, Kowada M, Sasajima H. Vascular malformation of the brain in hereditary Haemorrhagic telangiectasia. Surg Neurol 1994; 41: 374-380.
14. Connors III JJ, Wojak JC. Intracranial arteriovenous malformations: general considerations. In: Connors III JJ, Wojak JC (eds): Interventional neuroradiology. WB Saunders company 1999, pp. 227-240.
15. Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg 1986; 65: 476-483.
16. Willemse RB, Mager JJ, Westermann CJ, Overtoom TT, Mauser H, Wolbers JG. Bleeding risk of cerebrovascular malformations in hereditary Haemorrhagic telangiectasia. J Neurosurg 2000; 92 (5): 779-84.
17. Morgan T, McDonald J, Anderson C, Ismail M, Miller F, Mao R, et al. Intracranial hemorrhage in infants and children with hereditary Haemorrhagic telangiectasia (Osler-Weber-Rendu Syndrome). Pediatrics 2002; 109 (1): e12.
18. Sabbà C, Pasculli G, Cirulli A, Gallitelli M, Virgilio G, Guastamacchia E, et al. Rendu-Osler-Weber disease: experience with 56 patients. Ann Ital Med Int 2002; 17: 173-179.
19. Pollock BE, Lunsford LD, Flickinger JC, Kondziolka D. The role of embolisation in combination with stereotactic radiosurgery in the management of pial and dural arteriovenous malformations. In: Connors III JJ, Wojak JC (eds): Interventional neuroradiology. WB Saunders company 1999, pp. 267-275.
20. Alves OL, Daugherty WP, Rios M. Arterial hyperoxia in severe head injury: a useful or harmful option? Curr Pharm Des 2004; 10(18): 2163-76.
21. Martinez FJ, Simon RH. Clinical implications of macrolide therapy in chronic sinopulmonary diseases. Curr Pharm Des 2004; 10(25): 3095-110.
22. Psarras S, Caramori G, Contoli M, Papadopoulos N, Papi A. Oxidants in asthma and in chronic obstructive pulmonary disease (COPD). Curr Pharm Des 2005; 11(16): 2053-62.